Cardiovascular Institute of the South Is First in the World to Use New Drug-Coated Balloon to Treat Leg Artery Blockages
May 24, 2024 – Lafayette, LA – Cardiovascular Institute of the South (CIS) is the first in the world to use the 200-cm RANGER Drug-Coated Balloon to treat peripheral artery disease (PAD) in the legs. CIS interventional cardiologist Dr. Ankur Lodha was the first to use this new balloon on May 20 at the CIS Office Based Lab in Lafayette, Louisiana.
Distributed by Boston Scientific, the RANGER 200-cm Monorail Drug-Coated Balloon is the first device of its kind made with a long 200-cm shaft, allowing interventionalists to treat blocked arteries in the upper leg using a small access point in the wrist. This approach is minimally invasive and more comfortable for patients. The device is easy to guide through the body and delivers medication directly to the blockage, helping to keep the artery open.
“Using this balloon through the radial approach–from the wrist rather than the groin–offers a safer option for our patients. It’s more comfortable for patients and allows them to get back on their feet sooner after the procedure,” said Dr. Lodha. “This is a truly innovative step forward in how we treat peripheral artery disease (PAD) in the legs.”
PAD is a condition where arteries in the legs become narrowed reducing blood flow. It can cause leg pain and mobility issues and also increases the risk of heart attack, stroke, and limb amputation.
To learn more about PAD, or to schedule an appointment with a CIS cardiologist, visit www.cardio.com.
About Cardiovascular Institute of the South
Founded by Dr. Craig Walker in 1983, Cardiovascular Institute of the South (CIS) is a world-leader in preventing, detecting and treating cardiovascular and peripheral vascular disease. CIS offers a comprehensive heart and vascular program with expert physicians trained in many specialties, including internal medicine, nuclear cardiology, electrophysiology, lipid management, coronary artery disease, peripheral vascular disease, valve disease, venous disease and interventional procedures. CIS has earned international acclaim as a pioneer of research, development and education, as well as an innovator in the treatment of peripheral vascular disease. With a dedicated team of more than 1,150 team members, CIS provides comprehensive cardiovascular care at 23 locations across Louisiana and Mississippi, with 11 telemedicine programs. CIS remains at the forefront of technology, providing the highest-quality, compassionate care. This mission has guided the institute for more than 42 years of excellence. For more information about CIS, call 1-800-425-2565 or visit www.cardio.com.
